Berwyn biotech firm taking on Alzheimer’s disease receives $1.7M NIH grant

The grant will support long-term toxicology studies of the company’s lead compound.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.